Turkey · Delayed Price · Currency is TRY IST:SURGY Statistics
Total Valuation
IST:SURGY has a market cap or net worth of TRY 9.08 billion. The enterprise value is 9.04 billion.
| Market Cap | 9.08B |
| Enterprise Value | 9.04B |
Important Dates
The last earnings date was Tuesday, March 3, 2026.
| Earnings Date | Mar 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IST:SURGY has 167.50 million shares outstanding.
| Current Share Class | 165.43M |
| Shares Outstanding | 167.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.07% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 9.30.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 9.30 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.00 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.25 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.09
| Current Ratio | 21.09 |
| Quick Ratio | 0.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.61 |
Financial Efficiency
Return on equity (ROE) is 11.40% and return on invested capital (ROIC) is 3.84%.
| Return on Equity (ROE) | 11.40% |
| Return on Assets (ROA) | -0.85% |
| Return on Invested Capital (ROIC) | 3.84% |
| Return on Capital Employed (ROCE) | -1.38% |
| Weighted Average Cost of Capital (WACC) | 4.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 97.67M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.34B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.27% in the last 52 weeks. The beta is 0.13, so IST:SURGY's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +38.27% |
| 50-Day Moving Average | 57.67 |
| 200-Day Moving Average | 52.22 |
| Relative Strength Index (RSI) | 39.62 |
| Average Volume (20 Days) | 4,951,934 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -175.57M |
| Pretax Income | -360.96M |
| Net Income | 976.65M |
| EBITDA | -173.38M |
| EBIT | -175.57M |
| Earnings Per Share (EPS) | 5.83 |
Balance Sheet
The company has 39.67 million in cash and n/a in debt, with a net cash position of 39.67 million or 0.24 per share.
| Cash & Cash Equivalents | 39.67M |
| Total Debt | n/a |
| Net Cash | 39.67M |
| Net Cash Per Share | 0.24 |
| Equity (Book Value) | 9.06B |
| Book Value Per Share | 54.09 |
| Working Capital | 2.22B |
Cash Flow
| Operating Cash Flow | -703.50M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IST:SURGY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 10.76% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |